Benjamin Levine Ebert is the Chair of Medical Oncology at the Dana–Farber Cancer Institute and the George P. Canellos, MD and Jean S. Canellos Professor of Medicine at Harvard Medical School. Ebert is the president-elect and CEO of Dana-Farber effective October 1, 2024 succeeding Laurie Glimcher.
